A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Matti Aapro, H. S. Rugo, Giada Rizzi, Maria Elisa Borroni, Igor Bondarenko, Tomasz Sarosiek, Cristina Oprean, Servando Cardona‐Huerta, Vito Lorusso, M. Karthaus,

Annals of Oncology · 2014 · 248 citations · 9 references

DOIFull text

Open access

Concepts

References

9